Home › Funds › Novo Holdings A/S › CLDX

Novo Holdings A/S position in CLDX

CELLDEX THERAPEUTICS INC NEW · Health Care

Novo Holdings A/S reported holding 950,000 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q3 2026 13F filing — a position valued at US$30.8M, representing 2.07% of its reported portfolio and ranking #16 among its reported holdings. Novo Holdings A/S has disclosed CLDX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)950.00K sh
Reported value held$30.79M
Portfolio Weight2.07%
First reportedQ2 2024
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Novo Holdings A/S's CLDX position evolved

Novo Holdings A/S first disclosed a stake in CLDX in Q2 2024 at 850,000 shares (US$31.5M). The position peaked in Q2 2026 at 1,025,000 shares, worth US$38.1M. Across 10 filings, Novo Holdings A/S increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 950,000 shares valued at US$30.8M — a reduction of -75,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2024 850.00K $31.46M New
Q3 2024 963.66K $32.75M Add
Q4 2024 1.00M $25.27M Add
Q1 2025 1.20M $21.78M Add
Q2 2025 1.20M $24.42M Hold
Q3 2025 1.20M $31.04M Hold
Q4 2025 1.20M $32.59M Hold
Q1 2026 1.20M $38.06M Hold
Q2 2026 1.02M $38.14M Reduce
Q3 2026 950.00K $30.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDX and 13F data

CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 35 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$164.2M), BAKER BROS. ADVISORS LP (US$83.1M), Deep Track Capital, LP (US$68.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDX

All CLDX fund holders →

FAQ

How long has Novo Holdings A/S held CLDX?

Novo Holdings A/S has disclosed CLDX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Novo Holdings A/S's current position in CLDX?

As of Q3 2026, Novo Holdings A/S holds 950.00K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $30.79M, representing 2.07% of its reported portfolio and ranking #16.

Has Novo Holdings A/S been buying or selling CLDX?

In the latest 13F filing (Q3 2026), Novo Holdings A/S reduced its position in CLDX. The position peaked in Q2 2026 at 1.02M shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, BAKER BROS. ADVISORS LP, Deep Track Capital, LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.